The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis
Abstract
Summary: Mild hyperhomocysteinemia has been identified as a risk factor for arterial disease and for venous thrombosis. Individuals homozygous for the thermolabile variant of the methylene tetrahydrofolate reductase gene (MTHFR) which results from a common mutation Ala677→Val and is found in 5-15% of the general population, have significantly elevated plasma homocysteine levels and may account for one of the genetic risk factors in vascular disease. We have analyzed the prevalence of MTHFR-T homozygotes in patients with arterial disease or venous thrombosis. We studied 191 patients with arterial disease and 127 individuals with venous thrombosis and compared with 296 unmatched controls. The results showed that there was a high prevalence of homozygotes for the mutated MTHFR-T allele among a group of patients with arterial disease (19%) in the absence of hyperlipoproteinemia, hypertension, and diabetes mellitus when compared to controls (4%), odds ratio of 5.52 (95% C.I., 2.27 to 13.51). The prevalence of homozygotes among patients with venous thrombosis was 11%, odds ratio of 2.93 (95% C.I., 1.23 to 7.01). The risk of venous thrombosis remained high, odds ratio of 2.63, even after we excluded 27 patients with hereditary thrombophilia (e.g. factor V Leiden, dysfibrinogene- mia, deficiency of protein C, protein S, antithrombin III, or factor XII) from the 127 overall cases with venous thrombosis. These data support the hypothesis that being a homozygote for the MTHFR-T is a risk factor for the development of arterial diasease and also for venous thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
den Heijer, M., Koster, T., Blom, H. J., Bos, G. M. J., Briët, E., Reitsma, P. H., Vandenbroucke, J. P., & Rosendaal, F. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341203 · Cited by 1,044
Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular Disease
Kang, S. S., Wong, P. W. K., & Malinow, M. R. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.001431 · Cited by 762
Kluijtmans, L. A. J., van den Heuvel, L. P., Boers, G. H. J., Frosst, P. D., Stevens, E. M., van Oost, B. A., den Heijer, M., Trijbels, F. J. M., Rozen, R. R., & Blom, H. J. (1996) · PubMed · Cited by 753
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Ueland, P. M., & Refsum, H. (1989) · PubMed · Cited by 688
Cited by
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Selhub, J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.217 · Cited by 1,186
5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: A HuGE Review
Botto, L. D., & Yang, Q. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010290 · Cited by 1,044
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders
Mattson, M. P., & Shea, T. B. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00032-8 · Cited by 847
Metadata
- Authors
- Arruda, V. R., von Zuben, P. M., Chiaparini, L. C., Annichino-Bizzacchi, J. M., & Costa, F. F.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1997
- Volume
- 77
- Issue
- 05
- Pages
- 0818-0821
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W149972145
- Cited by
- 296
- References
- 27
- FWCI
- 22.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis. https://app.cochat.ai/papers/10.1055/s-0038-1656059
- The paper
- Arruda, V. R., von Zuben, P. M., Chiaparini, L. C., Annichino-Bizzacchi, J. M., & Costa, F. F. (1997). The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0038-1656059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.